54 related articles for article (PubMed ID: 1043)
1. [Clinical trial of a novel benzodiazepine derivative in a double-blind study using the Wittenborn psychiatric rating scale (author's transl)].
Husser J; Seffen J; Wolf GK
Arzneimittelforschung; 1975 Oct; 25(10):1650. PubMed ID: 1043
[TBL] [Abstract][Full Text] [Related]
2. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
Andreoli V; Maffei F; Montanaro N; Morandini G
Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
[TBL] [Abstract][Full Text] [Related]
3. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
Aden GC; O'Hair DE
Clin Ther; 1980; 3(3):209-18. PubMed ID: 6109568
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
7. Bromazepam ('Lexotanil') compared with placebo: a double-blind, crossover study.
Rey A; Bovet J; Schneider PB
Pharmatherapeutica; 1984; 4(1):13-20. PubMed ID: 6150491
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
Pinosky DG
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
[TBL] [Abstract][Full Text] [Related]
9. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
10. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
Hart WL; Parmley LF
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
[TBL] [Abstract][Full Text] [Related]
11. Treatment of anxiety with ketazolam in elderly patients.
Bresolin N; Monza G; Scarpini E; Scarlato G; Straneo G; Martinazzoli A; Benincà G; Cattoni C; De Candia R; Belloni G
Clin Ther; 1988; 10(5):536-42. PubMed ID: 2908803
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of bromazepam. Thirty cases (author's transl)].
Sechter D; Petitjean F; Bitoun G
Nouv Presse Med; 1982 May; 11(22):1744-6. PubMed ID: 6124949
[TBL] [Abstract][Full Text] [Related]
14. [A double-blind comparison between mianserin and imipramine (author's transl)].
Pull CB; Pichot P; Dreyfus JF
Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam in the treatment of neurotic anxiety.
Kerry RJ; McDermott CM
Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
[TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
18. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.
Ballenger JC; McDonald S; Noyes R; Rickels K; Sussman N; Woods S; Patin J; Singer J
Psychopharmacol Bull; 1991; 27(2):171-9. PubMed ID: 1681563
[TBL] [Abstract][Full Text] [Related]
19. Camazepam versus placebo. A double-blind clinical study on geriatric patients suffering from psychic complaints. Short Communication.
Tammaro A; Picceo MT; Gemmellaro P; Bonaccorso O
Arzneimittelforschung; 1977; 27(11):2177-8. PubMed ID: 23793
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].
Carpentier PH; Mathieu M
J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]